Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

3.56
Delayed Data
As of 3:59pm ET
 +0.03 / +0.85%
Today’s Change
3.20
Today|||52-Week Range
10.04
-3.00%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Corvus Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +152.81% increase from the last price of 3.56.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Corvus Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.42
Sales
$0.00
Reporting Date
Nov 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.68%
 
 
 
 
 
 
Growthannually 6.58%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.